Employees Retirement System of Texas’s Standard BioTools LAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-165,000
Closed -$264K 537
2022
Q2
$264K Hold
165,000
﹤0.01% 690
2022
Q1
$592K Hold
165,000
0.01% 690
2021
Q4
$647K Hold
165,000
0.01% 697
2021
Q3
$1.09M Buy
+165,000
New +$1.09M 0.01% 646

Other funds holding LAB

Employees Retirement System of Texas's LAB Position: Q3 2022 in Review

Employees Retirement System of Texas sold out of Standard BioTools (LAB) in Q3 2022, closing a stake of 165,000 shares — an estimated $264K sold.

Employees Retirement System of Texas first reported a position in LAB in Q3 2021 and held it in 4 quarters. The position peaked at $1.09M in Q3 2021. 65 funds tracked by Wall St. Rank hold LAB as of Q3 2022.

  • Employees Retirement System of Texas reported no remaining Standard BioTools position as of Q3 2022 after selling out during the quarter.
  • Employees Retirement System of Texas sold 165,000 Standard BioTools shares in Q3 2022, an estimated $264K.
  • Employees Retirement System of Texas first reported a position in Standard BioTools in Q3 2021 and held it in 4 quarters.
  • Employees Retirement System of Texas's Standard BioTools position peaked at $1.09M in Q3 2021.
  • 65 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2022.

Based on Employees Retirement System of Texas's 13F filing for Q3 2022, filed 10 Nov 2022.